Outcomes of allogeneic hematopoietic cell transplantation (HCT) in patients with myelofibrosis (MF) exposed to JAK1/2 inhibitors Meeting Abstract


Authors: Shanavas, M.; Popat, U.; Michaelis, L. C.; Fauble, V.; McLornan, D.; Klisovic, R.; Mascarenhas, J.; Tamari, R.; Arcasoy, M.; Davies, J.; Gergis, U.; Ukaegbu, O.; Kamble, R.; Storring, J.; Majhail, N. S.; Romee, R.; Lew, J.; Pagliuca, A.; Vasu, S.; Ernst, B.; Atenafu, E.; Hanif, A.; Champlin, R.; Hari, P.; Gupta, V.
Abstract Title: Outcomes of allogeneic hematopoietic cell transplantation (HCT) in patients with myelofibrosis (MF) exposed to JAK1/2 inhibitors
Meeting Title: 20th Congress of the European Hematology Association (EHA)
Journal Title: Haematologica
Volume: 100
Issue: Suppl. 1
Meeting Dates: 2015 Jun 11-14
Meeting Location: Vienna, Austria
ISSN: 0390-6078
Publisher: Ferrata Storti Foundation  
Date Published: 2015-06-01
Start Page: 162
End Page: 163
Language: English
ACCESSION: WOS:000361204901355
PROVIDER: wos
PMCID: PMC4480587
Notes: Meeting Abstract: S450 -- Source: Wos
MSK Authors
  1. Roni Tamari
    208 Tamari